This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Forty‐three key gene expressions involved in the effect of indoleamine 2, 3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2, 3‐dioxygenase 1 inhibitor biomarker. Issue 2 (17th February 2021)
Record Type:
Journal Article
Title:
Forty‐three key gene expressions involved in the effect of indoleamine 2, 3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2, 3‐dioxygenase 1 inhibitor biomarker. Issue 2 (17th February 2021)
Main Title:
Forty‐three key gene expressions involved in the effect of indoleamine 2, 3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2, 3‐dioxygenase 1 inhibitor biomarker